Physician profile
Deepa B Iyer
NPI 1174755144
$4,376.96
in general payments reported to CMS, 2019-2025
23 companies · $635 in 2025
The $635 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $71.58 · 2021: $472 · 2022: $680 · 2023: $493 · 2024: $1,846 · 2025: $635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,005 · Travel and Lodging: $881 · Education: $88.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,004.70 |
| Travel and Lodging | $881.42 |
| Education | $88.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,693.68 | 2019-2025 | Impella |
| Abbott Laboratories | $1,522.39 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Actelion Pharmaceuticals US, INC. | $192.09 | 2019-2024 | Uptravi, Opsumit |
| One Lambda, INC. | $100.73 | 2025 | |
| Edwards Lifesciences Corporation | $96.80 | 2025 | Sapien 3 Ultra Resilia |
| Biosense Webster, INC. | $89.42 | 2023 | Qdot Micro Catheter |
| Cardiva Medical, INC. | $89.37 | 2023 | Cardiva Vascade 6/7f Vcs |
| Novartis Pharmaceuticals Corporation | $87.75 | 2019-2021 | |
| Irhythm Technologies, INC. | $85.24 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Merck Sharp & Dohme LLC | $76.90 | 2022-2024 | Verquvo, Winrevair |
| Pfizer INC. | $44.50 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $36.01 | 2022 | |
| United Therapeutics Corporation | $35.31 | 2023-2025 | Tyvaso, Tyvaso |
| Si-Bone, INC. | $32.18 | 2022 | |
| Abbvie INC. | $29.73 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ancora Heart, INC. | $28.15 | 2024 | Accucinch |
| Impulse Dynamics (USA) INC. | $27.05 | 2023 | Optimizer |
| Takeda Pharmaceuticals U.S.A., INC. | $22.34 | 2023 | Livtencity |
| Scpharmaceuticals INC. | $20.94 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.06 | 2025 | |
| Cvrx, INC. | $19.32 | 2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.87 | 2024 | Lifevest |
| Akcea Therapeutics, INC. | $11.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepa Iyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.